Clinical Validation Study of RTVue Features
Completed
- Conditions
- HealthyGlaucoma
- Registration Number
- NCT01370850
- Lead Sponsor
- Optovue
- Brief Summary
To perform a clinical validation study of RTVue features in volunteers with various ocular pathology or no ocular pathology.
- Detailed Description
Clinical validation study of RTVue features in volunteers with various ocular pathology or no ocular pathology. Subjects to undergo a clinical exam and OCT scanning.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 53
Inclusion Criteria
- Normal subjects will have normal results from the clinical exam and be free of ocular pathology.
- Glaucoma patients will have clinical exam results consistent with glaucoma; they will have visual field defects consistent with glaucoma and/or structural damage consistent with glaucoma.
- Retina patients will have clinical exam results consistent with retina pathology.
Exclusion Criteria
- Normal subjects will be free of any ocular pathology.
- Glaucoma patients will be free of any ocular pathology except glaucoma.
- Retina patients will be free of any ocular pathology except any type of retina pathology.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retina measurement at time of study visit (day 1)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie RTVue OCT imaging in detecting glaucomatous retinal changes?
How does RTVue OCT compare to standard-of-care imaging techniques in glaucoma diagnosis and monitoring?
Which biomarkers are most predictive of glaucoma progression using RTVue OCT parameters?
What adverse events are associated with RTVue OCT scanning in ocular disease populations?
Are there combination approaches or competitor devices that enhance RTVue OCT's clinical utility in glaucoma management?
Trial Locations
- Locations (1)
Pacific Eye Specialists
🇺🇸Daly City, California, United States
Pacific Eye Specialists🇺🇸Daly City, California, United States